Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
The Clinical Trial Financial Analyst will report to the Director of the Clinical Trial Business Office at the Dana-Farber Cancer Institute. The Clinical Trial Financial Analyst will assist the Business Director in all financial aspects of clinical trials at Dana-Farber Cancer Institute. The Clinical Trial Financial Analyst will also work directly with multiple groups and individuals across the Institute to communicate clinical trial financial objectives and results. The ideal candidate has had exposure to clinical trials and/or experience at a medical center, pharmaceutical/biotechnology company, or Clinical Trial Organization (CRO).
Clinical Trial Study Budgets
Financial Responsibilities and Oversight
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.